SCHEMBL19745090

SCHEMBL19745090

CC(C)(C)OC(=O)NC(CC1CCCCC1)C(=O)N1C[C@H](N2CCCCC2)C[C@H]1C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CTSS P25774 2/20 0.50
CTSK P43235 2/20 0.50
HTRA1 Q92743 12/20 0.46
AGTR2 P50052 1/20 0.42
ACE P12821 1/20 0.40
ITGB3 P05106 4/20 0.39
ITGA2B P08514 4/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19745089 1.00 CTSS (0.50) CTSSCTSKHTRA1AGTR2ACE
SCHEMBL21119405 0.91 CTSS (0.47) CTSSCTSKHTRA1AGTR2
SCHEMBL21488665 0.86 CTSS (0.53) CTSSCTSKHTRA1ACEITGB3
SCHEMBL19747959 0.86 CTSS (0.53) CTSSCTSKHTRA1ACEITGB3
SCHEMBL19744673 0.83 CTSS (0.56) CTSSCTSKACE
SCHEMBL19744672 0.83 CTSS (0.56) CTSSCTSKACE
SCHEMBL19744561 0.81 HTRA1 (0.58) HTRA1
SCHEMBL19747491 0.81 HTRA1 (0.58) HTRA1
SCHEMBL28777990 0.81 HTRA1 (0.58) HTRA1
SCHEMBL19744562 0.81 HTRA1 (0.58) HTRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3472130-B1 ALIPHATIC PROLINAMIDE DERIVATIVES Orion Ophthalmology LLC (US) 2022-02-16 EP disclosed
US-11091465-B2 2021-08-17 US disclosed
US-20200385362-A1 CARBOCYCLIC PROLINAMIDE DERIVATIVES Orion Ophthalmology LLC (US) 2020-12-10 US disclosed
US-10730832-B2 Aliphatic prolinamide derivatives Orion Ophthalmology LLC (US) 2020-08-04 US disclosed
US-20190330146-A1 ALIPHATIC PROLINAMIDE DERIVATIVES Orion Ophthalmology LLC (US) 2019-10-31 US disclosed
EP-3472130-A1 ALIPHATIC PROLINAMIDE DERIVATIVES ORION OPTHALMOLOGY LLC (US) 2019-04-24 EP disclosed
WO-2017222917-A1 ALIPHATIC PROLINAMIDE DERIVATIVES INCEPTION 4, INC. (US) 2017-12-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10730832-B2 Aliphatic prolinamide derivatives HTRA1, ALDH1A2, PREP CTSS 746/4885CTSK 1449/4885HTRA1 1/4885
US-20200385362-A1 CARBOCYCLIC PROLINAMIDE DERIVATIVES HTRA1, ADCYAP1R1, HTRA2 CTSS 402/4885CTSK 983/4885HTRA1 1/4885
US-20190330146-A1 ALIPHATIC PROLINAMIDE DERIVATIVES HTRA1, ALDH1A2, PREP CTSS 746/4885CTSK 1449/4885HTRA1 1/4885
US-11091465-B2 HTRA1, ALDH1A2, ADCYAP1R1 CTSS 341/4885CTSK 823/4885HTRA1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.